{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:34:56Z","timestamp":1793313296997,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11033-020-05862-0","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T15:02:40Z","timestamp":1603292560000},"page":"9201-9205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-0645","authenticated-orcid":false,"given":"Simone","family":"Agostini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Saul","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca Rosa","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"5862_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","volume":"1","author":"BL Padgett","year":"1971","unstructured":"Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257\u20131260","journal-title":"Lancet"},{"key":"5862_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-012-0080-7","volume":"18","author":"A Belizzi","year":"2012","unstructured":"Belizzi A, Nardis C, Anzivino E, Rodio D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V (2012) Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol 18:1\u201311","journal-title":"J Neurovirol"},{"key":"5862_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1743-422X-11-158","volume":"11","author":"O Lagatie","year":"2014","unstructured":"Lagatie O, Van Loy T, Tritsmans L, Stuyver L (2014) Viral miRNAs in plasma and urine divulge JC polyomavirus infection. Virol J 11:158","journal-title":"Virol J"},{"key":"5862_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/ene.13906","volume":"26","author":"T Bartsch","year":"2019","unstructured":"Bartsch T, Rempe T, Leypoldt F, Riedel C, Jansen O, Berg D, Deuschl G (2019) The spectrum of progressive multifocal leukoencephalopathy, a practical approach. Eur J Neurol 26:566\u2013541","journal-title":"Eur J Neurol"},{"key":"5862_CR5","first-page":"179","volume":"41","author":"V Pietropaolo","year":"2018","unstructured":"Pietropaolo V, Prezioso C, Bagnato F, Antonelli G (2018) John Cunningham virus, an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopaty. New Microbiol 41:179\u2013186","journal-title":"New Microbiol"},{"key":"5862_CR6","doi-asserted-by":"publisher","first-page":"9823","DOI":"10.1128\/JVI.01144-08","volume":"82","author":"GJ Seo","year":"2008","unstructured":"Seo GJ, Fink LH, O\u2019Hara B, Atwood WJ, Sullivan CS (2008) Evolutionarily conserved function of a viral microRNA. J Virol 82:9823\u20139828","journal-title":"J Virol"},{"key":"5862_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2015.01.019","volume":"65","author":"T Pietila","year":"2015","unstructured":"Pietila T, Nummi M, Auvinen P, Mannone L, Auvinen E (2015) Expression of BKV and JCV encoder microRNA in human cereborpsinal fluid; plasma and urine. J Clin Virol 65:1\u20135","journal-title":"J Clin Virol"},{"key":"5862_CR8","doi-asserted-by":"publisher","first-page":"e100036","DOI":"10.1371\/journal.pone.0100036","volume":"9","author":"A Link","year":"2014","unstructured":"Link A, Balaguer F, Nagasaka T, Boland CR, Goel A (2014) MicroRNA miR-J1-5p as a potential biomarker for JCV virus infection in the gastrointestinal tract. PLoS ONE 9:e100036","journal-title":"PLoS ONE"},{"key":"5862_CR9","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s00705-017-3542-7","volume":"162","author":"C Prezioso","year":"2017","unstructured":"Prezioso C, Scribano D, Bellizzi A, Anzivino E, Rodio DM, Trancassini M, Palamara AT, Pietropaolo V (2017) Efficient propagation of archetype JC polyomavirus in COS-7 cells, evaluation of rearrangements within the NCCR structural organization after transfection. Arch Virol 162:3745\u20133752","journal-title":"Arch Virol"},{"key":"5862_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12985-018-0939-1","volume":"15","author":"C Prezioso","year":"2018","unstructured":"Prezioso C, Scribano D, Rodio DM, Ambrosi C, Trancassini M, Palamara AT, Pietropaolo V (2018) COS-7-based model: methodological approach to study John Cunningham virus replication cycle. Virol J 15:29","journal-title":"Virol J"},{"key":"5862_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0092-8674(81)90282-8","volume":"23","author":"Y Guizman","year":"1981","unstructured":"Guizman Y (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175\u2013182","journal-title":"Cell"},{"key":"5862_CR12","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1128\/JVI.72.7.5335-5342.1998","volume":"72","author":"K Hara","year":"1998","unstructured":"Hara K, Sugimoto C, Kitamura T, Aoki N, Taguchi F, Yogo Y (1998) Archetype JC virus efficiently replicates in COS-7 cells; simian cells constitutively expressing simian virus 40 T antigen. J Virol 72:5335\u20135342","journal-title":"J Virol"},{"key":"5862_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.virusres.2015.11.026","volume":"2013","author":"I Giovannelli","year":"2016","unstructured":"Giovannelli I, Clausi V, Nukuzuma S, Della MN, Nosi D, Giannecchini S (2016) Polyomavirus JC microRNA expression after infection in vitro. Virus Res 2013:269\u2013273","journal-title":"Virus Res"},{"key":"5862_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13550280590900382","volume":"11","author":"S Delbue","year":"2005","unstructured":"Delbue S, Sotgiu G, Fumagalli D, Valli M, Borghi E, Mancuso R, Marchioni E, Maserati R, Ferrante P (2005) A case of PML patient with four different JC virus TCR rearrangements in CSF; blood; serum and urine. J Neurovirol 11:51\u201357","journal-title":"J Neurovirol"},{"key":"5862_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13365-014-0249-3","volume":"20","author":"GS Brunetto","year":"2014","unstructured":"Brunetto GS, Massoud R, Leibovitch EC, Caruso B, Johnson K, Ohayon J, Fenton K, Cortese I, Jacobson S (2014) Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM\/TSP patients and identification of viral mutations. J Neurovirol 20:341\u2013351","journal-title":"J Neurovirol"},{"key":"5862_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.24371","volume":"77","author":"HS Wollebo","year":"2015","unstructured":"Wollebo HS, White MK, Gordon J, Berger JR, Khalili K (2015) Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol 77:560\u2013570","journal-title":"Ann Neurol"},{"key":"5862_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","volume":"61","author":"EO Major","year":"2010","unstructured":"Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35\u201347","journal-title":"Annu Rev Med"},{"key":"5862_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/1941874412455338","volume":"3","author":"AA Pruitt","year":"2013","unstructured":"Pruitt AA, Graus F, Rosenfeld MR (2013) Neurological complications of transplantation, part I, hematopoietic cell transplantation. Neurohospitalist 3:24\u201338","journal-title":"Neurohospitalist"},{"key":"5862_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1474-4422(18)30040-1","volume":"17","author":"EO Major","year":"2018","unstructured":"Major EO, Yousry TA, Clifford DB (2018) Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol 17:437\u2013480","journal-title":"Lancet Neurol"},{"key":"5862_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/13550280600716604","volume":"12","author":"C Wuthrich","year":"2006","unstructured":"Wuthrich C, Kesari S, Kim WK, Williams K, Gelman R, Elmeric D, De Girolami U, Jospeh JT, Hedley-Whyte T, Koralnik IJ (2006) Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy, co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol 12:116\u2013128","journal-title":"J Neurovirol"},{"key":"5862_CR21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1212\/WNL.0000000000003739","volume":"88","author":"N Schwab","year":"2017","unstructured":"Schwab N, Schneider-Hohendorf T, Melzer N, Cutter G, Wiendl H (2017) Natalizumab-associated PML, challenges with incidence; resulting risk; and risk stratification. Neurology 88:1197\u20131205","journal-title":"Neurology"},{"key":"5862_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","volume":"10","author":"KR Carson","year":"2009","unstructured":"Carson KR, Focosi D, Major EO (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab; natalizumab and efalizumab, a review from the Research on Adverse Drug Events and Reports (RADAR) project. Lancet Oncol 10:816\u2013824","journal-title":"Lancet Oncol"},{"key":"5862_CR23","doi-asserted-by":"publisher","first-page":"G612","DOI":"10.1152\/ajpgi.90576.2008","volume":"296","author":"EC Ebert","year":"2009","unstructured":"Ebert EC (2009) Infliximab and the TNF-alpha system. Am J Physiol Gastrointest Liver Physiol 296:G612\u2013G620","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5862_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s13365-017-0560-x","volume":"23","author":"P Basnyath","year":"2017","unstructured":"Basnyath P, Virtanen E, Elovaara I, Hagman S, Auvinen E (2017) JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients. J Neurovirol 23:734\u2013741","journal-title":"J Neurovirol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05862-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:09:37Z","timestamp":1634774977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05862-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5862"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05862-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}